Smith & Nephew plc (BVMF:S1NN34)

Market Cap	80.49B +24.0%
Revenue (ttm)	32.56B +5.4%
Net Income	2.69B +61.0%
EPS	3.06 +59.9%
Shares Out	n/a
PE Ratio	29.92
Forward PE	16.77
Dividend	0.78 (2.27%)
Ex-Dividend Date	Oct 2, 2025

Volume	1
Average Volume	77
Open	34.40
Previous Close	34.50
Day's Range	34.40 - 34.40
52-Week Range	29.13 - 40.88
Beta	0.65
RSI	48.55
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: S1NN34

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD